Table 3.
Late grade 2 and higher treatment-related toxicities.
| Grade of Adverse Event | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2- Mod | 3-Severe | 4-LifeThr | 5-Lethal | Total | |||||
| n | (%) | n | (%) | n | (%) | n | (%) | ||
| Hematologic Adverse Events | |||||||||
| Hemoglobin | 1 | (2%) | 0 | (0%) | 0 | (0%) | 0 | (0%) | 61 |
| SUMMARY | |||||||||
| Maximum Hematologic AE | 1 | (2%) | 0 | (0%) | 0 | (0%) | 0 | (0%) | 61 |
| Non-Hematologic Adverse Events | |||||||||
| RTOG/EORTC Late Radiation Morbidity Scoring Scheme | |||||||||
| Bladder- Late RT Morbidity Scoring | 1 | (2%) | 0 | (0%) | 0 | (0%) | 0 | (0%) | 61 |
| Small/Large intestine-Late RT Morbidity Scori | 1 | (2%) | 0 | (0%) | 0 | (0%) | 0 | (0%) | 61 |
| Constitutional Symptoms | |||||||||
| Fatigue (asthenia, lethargy, malaise) | 2 | (3%) | 0 | (0%) | 0 | (0%) | 0 | (0%) | 61 |
| Endocrine | |||||||||
| Hot flashes/flushes | 1 | (2%) | 0 | (0%) | 0 | (0%) | 0 | (0%) | 61 |
| Gastrointestinal | |||||||||
| Proctitis | 2 | (3%) | 0 | (0%) | 0 | (0%) | 0 | (0%) | 61 |
| Pain | |||||||||
| Pain | 1 | (2%) | 0 | (0%) | 0 | (0%) | 0 | (0%) | 61 |
| Renal/Genitourinary | |||||||||
| Dysuria (painful urination) | 0 | (0%) | 2 | (3%) | 0 | (0%) | 0 | (0%) | 61 |
| Incontinence | 3 | (5%) | 0 | (0%) | 0 | (0%) | 0 | (0%) | 61 |
| Urinary frequency/urgency | 4 | (7%) | 0 | (0%) | 0 | (0%) | 0 | (0%) | 61 |
| Urinary retention (including neurogenic bladd | 3 | (5%) | 0 | (0%) | 0 | (0%) | 0 | (0%) | 61 |
| SUMMARY | |||||||||
| Maximum Overall AE | 12 | (20%) | 2 | (3%) | 0 | (0%) | 0 | (0%) | 61 |